Therapeutic Asset Ratings

3,272 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
FLUDEOXYGLUCOSE Sarcoma	National Cancer Institute (NCI)	P2	CCC (55)
Gilteritinib Myelodysplastic Syndrome	National Cancer Institute (NCI)	P2	CCC (55)
mk-2206 Renal Cell Carcinoma	National Cancer Institute (NCI)	P2	CCC (55)
NOGITECAN Chronic Myelomonocytic Leukemia	National Cancer Institute (NCI)	P2	CCC (55)
Olaparib Metastatic Malignant Neoplasm	National Cancer Institute (NCI)	P2	CCC (55)
Palbociclib Metastatic Malignant Neoplasm	National Cancer Institute (NCI)	P2	CCC (55)
Pomalidomide Chronic Myelomonocytic Leukemia	National Cancer Institute (NCI)	P2	CCC (55)
PREDNISONE TABLETS Acute Leukemia Of Ambiguous Lineage	National Cancer Institute (NCI)	P2	CCC (55)
Selumetinib Breast Cancer	National Cancer Institute (NCI)	P2	CCC (55)
Talazoparib Metastatic Malignant Neoplasm	National Cancer Institute (NCI)	P2	CCC (55)
Talazoparib Malignant Pancreatic Neoplasm	National Cancer Institute (NCI)	P2	CCC (55)
Taselisib Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (55)
Trastuzumab Deruxtecan Metastatic Malignant Neoplasm	National Cancer Institute (NCI)	P2	CCC (55)
Trastuzumab Emtansine Triple-Negative Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (55)
Veliparib Chronic Myelomonocytic Leukemia	National Cancer Institute (NCI)	P2	CCC (55)
Veliparib Melanoma	National Cancer Institute (NCI)	P2	CCC (55)
VEMURAFENIB Ependymoma	National Cancer Institute (NCI)	P2	CCC (55)
VEMURAFENIB Ewing Sarcoma	National Cancer Institute (NCI)	P2	CCC (55)
VEMURAFENIB Hepatoblastoma	National Cancer Institute (NCI)	P2	CCC (55)
VEMURAFENIB Langerhans Cell Histiocytosis	National Cancer Institute (NCI)	P2	CCC (55)
VEMURAFENIB Malignant Germ Cell Tumor	National Cancer Institute (NCI)	P2	CCC (55)
VEMURAFENIB Malignant Glioma	National Cancer Institute (NCI)	P2	CCC (55)
VEMURAFENIB Osteosarcoma	National Cancer Institute (NCI)	P2	CCC (55)
VEMURAFENIB Peripheral Primitive Neuroectodermal Tumor	National Cancer Institute (NCI)	P2	CCC (55)
VEMURAFENIB Central Nervous System Neoplasm	National Cancer Institute (NCI)	P2	CCC (55)

Showing 926 to 950 of 3,272 assets

PreviousPage 38 of 131Next